Overview
Rare cancers account for 20 per cent of cancers diagnosed in Australia, and 30 per cent of cancer-related deaths. People with rare cancers are more likely to die from their disease than people with more common cancers.
The outlook for people with rare cancers is not as good as that for people with more common cancers because:
- Rare cancers are often diagnosed at late, more advanced and harder to treat stages, because there are no effective screening strategies For patients and their health professionals may not recognise the symptoms of rare cancers
- Treatments for many rare cancers have not advanced at the same pace as treatments for more common cancers in recent years. This is because it is much harder to research or perform clinical trials for rarer diseases and there is often less support for researchers or clinicians.
The COSA Rare Cancers Group was established to help support and improve outcomes for patients with rare cancers. We work with community support groups such as Rare Cancers Australia (rarecancers.org.au) and the Cancer Council's Rare and Less Common Cancers Working Group.
We take an Australia-wide and international approach as collaborations are vital to more rapidly develop rare cancer knowledge and provide the most robust evidence-based for rare cancer patients.
Our membership is open to allied health and medical practitioners, and cancer researchers, with an interest in rare cancers. We also work with other tumour stream specialty groups to promote and develop rare cancer trials and research.
Group information
Read the Rare Cancers Group Terms of Reference
Read the AGM Minutes from 7 December 2020
What’s the latest
Group Chair
Group Chair
Clare Scott
Rare Cancers Group Chair & ANZGOG Representative
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 10 hours ago
RT @ACSC_PeterMac: Calling all clinicians interested in survivorship care for #cancersurvivors with treatable but not curable cancers. Regi…
Read More >COSAoncology 10 hours ago
COSA's March eNews is in members' inboxes now ... ... or available to COSA members at https://t.co/DCJYUXIxl3 https://t.co/FW6f8nIXMg
Read More >COSAoncology yesterday
COSA is the national oncology community bringing together multidisciplinary health professionals across all cancers to advance care and improve outcomes. More on member benefits here: https://t.co/4Fw9lbNDrf https://t.co/EGBDBenLQp
Read More >COSAoncology 3 days ago
It only takes a few minutes to join COSA – Plus, join before 30 April 2024 and not only get bonus months of membership, but also save on member rates before prices increase for 2024! Join now: https://t.co/KyH4eMpIOp https://t.co/KuSX6hoRdv
Read More >COSAoncology 6 days ago
Make the most of your COSA membership savings! A discount applies if you’re a member of an Affiliated or Associated organisation. Plus - join before 30 April 2024 to get a saving on member rates before they increase for 2024. https://t.co/szOpiPmIr7 https://t.co/9bcc678y2C
Read More >COSAoncology 7 days ago
2023 was quite a year! COSA members will find the COSA Annual Report 2023 in their inboxes; everyone else can find it at https://t.co/a88OK0m92Z Contains reports from 36 COSA Groups and Affiliate Organisations, as well as overviews from the President, CEO and 2023 ASM Convenor. https://t.co/C1wQQLJQT7
Read More >COSAoncology 8 days ago
RT @LaceyJudith: National Symposium, few places left register now! @COSAoncology @COSA_Surviv @ABigaranAEP @davemiz_EP @DrNicolasHart @drc…
Read More >COSAoncology 9 days ago
RT @M_Jefford: Our correspondence, #OpenAccess in @JCO_ASCO today 🚨 shared care for #cancersurvivors is preferred by pts, cheaper for the h…
Read More >COSAoncology 9 days ago
RT @cancer_K2A: Another big day of great presentations at #WICC2024 If you’re interested in learning how #survonc & supportive care can im…
Read More >COSAoncology 9 days ago
Join or renew your COSA membership before 30 April 2024 to get bonus months of membership and a saving! https://t.co/KyH4eMpIOp https://t.co/8fIetrPa2t
Read More >